You may or may not have noticed, but we decided to extend our Indiegogo campaign! Our website is *almost* ready to roll, and in the meantime, we didn't want to leave gaps in our ability to serve our community—you! 😊 "Yeah, well, what happens if website isn't finished in the next two weeks" you ask? We'll switch our IGG campaign to In Demand, meaning you can purchase directly from our page, and we'll ship quick smart.
#Repost @beardbros_pharms (@get_repost)
Zelda Therapeutics Ltd has sponsored an observation autism trial in Chile, demonstrating successful results for treating the core symptoms of #autism with #medicinal cannabis extracts that Zelda is planning on taking into #clinical trials.
The results demonstrated that in a cohort of 21 patients (median age of 9 years 10 months), cannabis extracts were significantly more effective than conventional medicines used, including atypical antipsychotics, and these extracts were well tolerated by the patients overall.
Harry Karelis, executive chairman for Zelda, commented: "The results from this observational study are very exciting and supports the anecdotal evidence we have, showing the positive effect medicinal cannabis has on treating autism symptoms." Zelda will use this baseline data to design its clinical trials and generate rigorous scientific data that validates the clinical benefit of medicinal cannabis. "We hope that in the near future Zelda Therapeutics can provide an alternative treatment for sufferers of this condition which is of major global significance."